IL-2 (Newsummit Biopharma)

白细胞介素-2（上海新生源）

Report date: 2026/05/06 20:02:28

Base Information

Drug NameIL-2 (Newsummit Biopharma)
Drug Alias NameIL-2 vaccine (gastric cancer)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsGastrointestinal NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPending
Originator CompaniesShanghai Xinshengyuan Biological Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of Medicine
Inactive CompaniesShanghai Xinshengyuan Biological Medicine Co Ltd
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsGastrointestinal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A